BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 3:51:00 PM | Browse: 1267 | Download: 1697
 |
Received |
|
2013-10-13 22:57 |
 |
Peer-Review Started |
|
2013-10-15 13:57 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2013-12-04 21:23 |
 |
Revised |
|
2013-12-29 14:16 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-03-05 14:18 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-03-05 15:19 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
2014-04-18 14:02 |
 |
Typeset the Manuscript |
|
2014-05-07 15:17 |
 |
Publish the Manuscript Online |
|
2014-06-16 16:19 |
| Category |
Oncology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Prognostic and predictive significance of MSI in stages Ⅱ/Ⅲ colon cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Zacharenia Saridaki, John Souglakos and Vassilis Georgoulias |
| Funding Agency and Grant Number |
|
| Corresponding Author |
John Souglakos, MD, PhD, Department of Medical Oncology, University General Hospital of Heraklion, Voutes, PO BOX 1352, 71110 Heraklion, Crete, Greece. georgsec@med.uoc.gr |
| Key Words |
Microsatellite instability; Stage Ⅱ; Stage Ⅲ; Colon cancer; Predictive; Prognostic |
| Core Tip |
Adjuvant chemotherapy in patients with stage Ⅱ colon cancer is still a subject of controversy. Stage Ⅱ tumors are highly heterogeneous, with five-year relative overall survival rates ranging from 58.4% to 87.5%. Recently reported European Society for Medical Oncology guidelines suggest that microsatellite instability (MSI) should be evaluated in stage Ⅱ colorectal cancer patients in order to contribute in treatment decision-making regarding chemotherapy administration. The current report critically evaluates the prognostic and predictive impact of MSI status in patients with stage Ⅱ and stage Ⅲ colon cancer. |
| Publish Date |
2014-06-16 16:19 |
| Citation |
Saridaki Z, Souglakos J, Georgoulias V. Prognostic and predictive significance of MSI in stages Ⅱ/Ⅲ colon cancer. World J Gastroenterol 2014; 20(22): 6809-6814
|
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i22/6809.htm |
| DOI |
10.3748/wjg.v20.i22.6809 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.